Concepedia

E. Kontopodis

EK

Statistics

Publications

8

Citations

235

H-Index

8

Active since

2009

Affiliations

University Hospital of Heraklion(Current)

Hellenic Oncology Research Group

University of Crete

Chania General Hospital ”St. George”

University Hospital of Alexandroupolis

E. Kontopodis is an author at University Hospital of Heraklion specializing in chemotherapy, medicine, and oncology.

Publications per year

2009–2016

8

Publications

8

Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status

Aristea Kalikaki, Anastasios Koutsopoulos, Dora Hatzidaki et al. · Lung Cancer · 2009 · 90 citations

, , +12

A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

Athanasios Pallis, Athina Agelidou, Ioannis Varthalitis et al. · BMC Cancer · 2010 · 36 citations · Full text

, , +13

Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

Panagiotis Katsaounis, Sofia Agelaki, E. Kontopodis et al. · Cancer Chemotherapy and Pharmacology · 2015 · 22 citations

, , +14

A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC

Athanasios Pallis, Vassilis Chandrinos, Georgia Pavlakou et al. · Cancer Chemotherapy and Pharmacology · 2010 · 22 citations · Full text

, , +10

A phase II, open-label trial of bortezomib (VELCADE®) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer

E. Kontopodis, Nikolaos Kentepozidis, K. Syrigos et al. · Cancer Chemotherapy and Pharmacology · 2016 · 19 citations

, , +15

1–5 of 8